يعرض 1,141 - 1,160 نتائج من 1,804 نتيجة بحث عن '(( 13 1 decrease ) OR ( 10 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))*', وقت الاستعلام: 0.14s تنقيح النتائج
  1. 1141
  2. 1142
  3. 1143
  4. 1144

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) حسب Mohammed Ibn-Mas'ud, Danjuma

    منشور في 2023
    "…Conversely, patients with non-heart failure-related polypharmacy had increased risks of ICU admissions (aOR=1.78, 95% CI: 1.13 – 2.70). ConclusionIn an examination of a database of patients with chronic heart failure, major non-heart failure-related polypharmacy was associated with increased risks in intensive care admissions. …"
    احصل على النص الكامل
    احصل على النص الكامل
    احصل على النص الكامل
  5. 1145
  6. 1146
  7. 1147
  8. 1148
  9. 1149
  10. 1150
  11. 1151
  12. 1152
  13. 1153
  14. 1154
  15. 1155
  16. 1156
  17. 1157

    Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey حسب Turner, Stuart J.

    منشور في 2013
    "…Univariate sensitivity analysis highlighted that increasing the duration of voriconazole by >1.2 days or decreasing LAmB by >1.0 days changes the result. Monte Carlo Simulation resulted in 69.4% of simulations favouring voriconazole per patient treated.Conclusion: There is a strong likelihood that voriconazole is economically more favourable than LAmB in the empiric treatment of IFI in Turkey.…"
    احصل على النص الكامل
    احصل على النص الكامل
  18. 1158
  19. 1159
  20. 1160